CYTARABINE | A071868 | HOSPIRA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Abbott Laboratories FDA-1994-P-0257 Abbott Laboratories filed this citizen petition under Federal Food, Drug and Cosmetic Act Section 505(j)(2)(c) requesting permission to submit an abbreviated new drug application (ANDA) for Cytarabine Injection, a ready-to-use sterile solution containing 500 mg in a 25 ml vial for intravenous, intra | Other | 2017-07-11 | Withdrawn | Abbott Laboratories |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.